LB Pharmaceuticals’ chief medical officer Susan Gani Kozauer files initial beneficial ownership statement (Form 3)
LBRX•LB Pharmaceuticals filed a Form 3 naming Chief Medical Officer Susan Gani Kozauer, dated Sept. 14, 2026.
1. Form 3 filing
LB Pharmaceuticals filed a Form 3 naming Susan Gani Kozauer as chief medical officer, dated Sept. 14, 2026.
